CSL is trading at 53.87 as of the 18th of February 2026; that is 1.64 percent increase since the beginning of the trading day. The stock's open price was 53.0. CSL has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of November 2025 and ending today, the 18th of February 2026. Click here to learn more.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. The company has 964.43 M outstanding shares. More on CSL
CSL [CSLLY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mega-Cap' category with a current market capitalization of 103.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. CSL classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 964.43 M outstanding shares.
CSL has accumulated about 10.44 B in cash with 2.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.83.
Check CSL Probability Of BankruptcyOwnership AllocationCSL holds a total of 964.43 Million outstanding shares. Almost 99.93 percent of CSL outstanding shares are held by general public with 0.07 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check CSL Ownership Details
The company last dividend was issued on the 2nd of September 2022. CSL had 3:1 split on the 24th of October 2007. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.The quote for CSL is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CSL please contact Paul BA at 61 3 9389 1911 or go to https://www.csl.com.au.
CSL Investment Alerts
CSL generated a negative expected return over the last 90 days
CSL Market Capitalization
The company currently falls under 'Mega-Cap' category with a current market capitalization of 103.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CSL's market, we take the total number of its shares issued and multiply it by CSL's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
CSL Profitablity
The company has Profit Margin (PM) of 0.18 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.25 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.25.
Technical Drivers
As of the 18th of February 2026, CSL shows the Mean Deviation of 1.38, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,454). CSL technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
The output start index for this execution was zero with a total number of output elements of sixty-one. CSL Tanh Of Price Series is a hyperbolic price transformation function.
CSL Outstanding Bonds
CSL issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CSL uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CSL bonds can be classified according to their maturity, which is the date when CSL has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
CSL intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CSL pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
CSL's time-series forecasting models are one of many CSL's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CSL's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Our tools can tell you how much better you can do entering a position in CSL without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Companies Directory Now
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.